ARCHIVES

Afatinib Delays Tumor Growth In LUX-Head and Neck 1 Study

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Max Wicha Describes Michigan’s Restructuring Planning For Growth

May 7, 1999

The Tivozanib Timeline

May 10, 2013

Cause Of Allergic Reaction To Cetuximab Found

March 28, 2008

NCI, FDA, Correlogic To Begin Large Trial Of Protein Pattern Diagnostic System for Ovarian Cancer

June 28, 2002

University of Kansas Cancer Center Receives NCI Center Designation

July 13, 2012

NCI To Recomplete Frederick Contract To Start In 1977

October 17, 1975